Pular para o conteúdo principal

ETHNOS_APP

Início • Busca • Periódicos • Lista 0

Melina Wiedmann

Dados Biográficos

ID7965976
NOMEMelina Wiedmann
PRENOMESMelina
SOBRENOMEWiedmann
ASSINATURAWIEDMANN M
AFILIAÇÕESTechnische Universität Dresden
ORCID0000-0001-7250-4329
VERIFICADOSim
TOTAL DE OBRAS2
TOTAL DE CITAÇÕES0
TOTAL COMO AUTOR2
TOTAL COMO EDITOR0
PRIMEIRO ANO DE PUBLICAÇÃO2022
ANO MAIS RECENTE DE PUBLICAÇÃO2024
ÍNDICE H0
  • Evaluation of the multimodal Delta therapy for adolescents with substance use disorders

    Open Access•Lukas A Basedow, Sören Kuitunen-Paul et al.•ARTICLE•Frontiers in Psychiatry•2024

    DELTA showed small effects on SUD-related and depression-related variables. However, the interpretation is limited by the small sample size. Nonetheless, the DELTA intervention is viable in SUD outpatient treatment and will be further evaluated. Clinical trial registration : The study was registered at clinicaltrials.gov under NCT03444974. Registered February, 26th 2018 (https://clinicaltrials.gov/ct2/show/NCT03444974)

  • Attenuated Psychotic Symptoms in Adolescents With Chronic Cannabis and MDMA Use

    Open Access•Melina Wiedmann, Sören Kuitunen-Paul et al.•ARTICLE•Frontiers in Psychiatry•2022

    Our results indicate that MDMA use additional to cannabis use is associated with APS among adolescent SUD patients. Contrary to our expectations, we did not see an association of cannabis use and APS. We speculate that cannabis increases the risk for psychosis after a longer period of use and in combination with other risk factors, such as trauma history. Clinicians should screen for APS among SUD patients using MDMA and cannabis in order to adap…

Sem obras proeminentes nesta página.

  • Attenuated Psychotic Symptoms in Adolescents With Chronic Cannabis and MDMA Use

    Open Access•Melina Wiedmann, Sören Kuitunen-Paul et al.•ARTICLE•Frontiers in Psychiatry•2022

    Our results indicate that MDMA use additional to cannabis use is associated with APS among adolescent SUD patients. Contrary to our expectations, we did not see an association of cannabis use and APS. We speculate that cannabis increases the risk for psychosis after a longer period of use and in combination with other risk factors, such as trauma history. Clinicians should screen for APS among SUD patients using MDMA and cannabis in order to adap…

  • Evaluation of the multimodal Delta therapy for adolescents with substance use disorders

    Open Access•Lukas A Basedow, Sören Kuitunen-Paul et al.•ARTICLE•Frontiers in Psychiatry•2024

    DELTA showed small effects on SUD-related and depression-related variables. However, the interpretation is limited by the small sample size. Nonetheless, the DELTA intervention is viable in SUD outpatient treatment and will be further evaluated. Clinical trial registration : The study was registered at clinicaltrials.gov under NCT03444974. Registered February, 26th 2018 (https://clinicaltrials.gov/ct2/show/NCT03444974)

Medicine (2 obras) · Psychiatry (2 obras) · Psychology (2 obras) · Abstinence (1 obras) · Attention Deficit Hyperactivity Disorder (1 obras) · Behavioral and Psychological Studies (1 obras) · Cannabis (1 obras) · Cannabis and Cannabinoid Research (1 obras) · Child and Adolescent Psychosocial and Emotional Development (1 obras) · Clinical Psychology (1 obras)

Ethnos_APP • Projeto Open Source • Licença MIT • Frontend v2.0.0 • Privacidade e Cookies • Documentação da API: api.ethnos.app/docs • Código da API: GitHub • DOI: 10.5281/zenodo.17049435 • Código do Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae